Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 | +$536M | |
| 2 | +$466M | |
| 3 | +$375M | |
| 4 |
PNC Financial Services
PNC
|
+$316M |
| 5 |
Blackstone
BX
|
+$306M |
Top Sells
| 1 | +$889M | |
| 2 | +$535M | |
| 3 | +$485M | |
| 4 |
American Tower
AMT
|
+$378M |
| 5 |
UnitedHealth
UNH
|
+$371M |
Sector Composition
| 1 | Technology | 37.18% |
| 2 | Healthcare | 15.93% |
| 3 | Financials | 10.17% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
TransUnion
TRU
$14.6B
| $283M | 0.13% |
3,383,447
+23,442
|
|
||
152
Surgery Partners
SGRY
$1.72B
| $282M | 0.13% |
13,036,583
+81,667
|
|
||
|
MTSR
153
DELISTED
Metsera Inc
MTSR
| $280M | 0.13% |
5,352,751
+1,964,788
|
|
||
154
Core & Main
CNM
$9.43B
| $278M | 0.13% |
5,158,036
+317,453
|
|
||
|
SARO
155
StandardAero Inc
SARO
$9.51B
| $276M | 0.13% |
10,115,995
+2,385,632
|
|
||
156
Accenture
ACN
$129B
| $273M | 0.12% |
1,108,124
-506,082
|
|
||
157
Novartis
NVS
$311B
| $265M | 0.12% |
2,068,726
-110,096
|
|
||
158
Automatic Data Processing
ADP
$89.8B
| $263M | 0.12% |
896,280
-341,238
|
|
||
159
Micron Technology
MU
$438B
| $260M | 0.12% |
1,552,137
-477,467
|
|
||
160
Oneok
OKE
$54.1B
| $260M | 0.12% |
3,558,727
-3,387
|
|
||
161
O'Reilly Automotive
ORLY
$79.3B
| $258M | 0.12% |
2,395,283
-620,667
|
|
||
162
Canadian Natural Resources
CNQ
$96.3B
| $257M | 0.12% |
8,038,669
-176,196
|
|
||
163
Veralto
VLTO
$23.3B
| $255M | 0.12% |
2,387,663
+22,577
|
|
||
164
CVS Health
CVS
$99.6B
| $254M | 0.12% |
3,370,475
+354,812
|
|
||
165
Travere Therapeutics
TVTX
$2.67B
| $253M | 0.12% |
10,599,660
+1,058,390
|
|
||
166
OSI Systems
OSIS
$4.65B
| $249M | 0.11% |
1,000,291
-52,435
|
|
||
167
Lennar Class A
LEN
$24.7B
| $239M | 0.11% |
1,898,978
+1,856,769
|
|
||
168
Cooper Companies
COO
$14.8B
| $235M | 0.11% |
3,423,213
-297,078
|
|
||
169
PTC Therapeutics
PTCT
$5.66B
| $232M | 0.11% |
3,773,556
+598,541
|
|
||
170
CarMax
KMX
$6.03B
| $219M | 0.1% |
4,875,229
+46,760
|
|
||
171
Tyler Technologies
TYL
$15.8B
| $216M | 0.1% |
412,559
+9,232
|
|
||
172
Sensient Technologies
SXT
$3.88B
| $215M | 0.1% |
2,286,148
-46,556
|
|
||
173
Descartes Systems
DSGX
$6.21B
| $214M | 0.1% |
2,269,917
+1,634,878
|
|
||
174
Burlington
BURL
$19B
| $213M | 0.1% |
836,618
+5,632
|
|
||
175
Ecolab
ECL
$79.5B
| $213M | 0.1% |
777,278
+134,995
|
|